CureVac SG&A Expense (Quarterly) Trends

CureVac NV (CVAC)

3.485 -0.18 (-5.04%) USD | NASDAQ | Jun 17, 16:00

3.485 0.00 (0.00%) After-Hours: 16:43

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	18.25M
December 31, 2023	23.35M
September 30, 2023	17.40M
June 30, 2023	20.79M
March 31, 2023	21.16M
December 31, 2022	24.20M
September 30, 2022	22.24M
June 30, 2022	24.59M
March 31, 2022	23.10M
December 31, 2021	16.68M

Date	Value
September 30, 2021	32.06M
June 30, 2021	32.76M
March 31, 2021	23.98M
December 31, 2020	21.06M
September 30, 2020	10.78M
June 30, 2020	16.15M
March 31, 2020	11.12M
December 31, 2019	16.55M
September 30, 2019	10.12M
March 31, 2019	6.440M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

10.12M

Minimum

Sep 2019

32.76M

Maximum

Jun 2021

20.33M

Average

21.06M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks